Hansen settles SEC investigation as ex-employees charged with fraud
This article was originally published in Clinica
Executive Summary
Robotic surgery specialist Hansen Medical has resolved an investigation, without incurring any charges, by the US Securities and Exchange Commission into alleged fraud committed by two former employees a few years ago. The probe, which dates back to 2009, followed the discovery of improper practices in certain areas of Hansen's operations, forcing the company to restate its financial results (www.clinica.co.uk, 23 November 2009). The agency had charged Hansen with "providing misleading financial information to public investors".
You may also be interested in...
What are the hottest innovations from Israel?
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
EuroPCR: St Jude and Philips talk up rival intravascular imaging techs
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
EuroPCR: Medtronic's drug-coated balloon keeps rising
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.